Home / AbbVie Inc. (ABBV)

AbbVie Inc. (ABBV) Technical Analysis

Updated: 2026-06-16 09:30 UTC · Last close: 221.59 (-2.70%) · Support: 220.42 · Resistance: 244.38
AbbVie Inc. (ABBV) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
220.42
⬆️ Resistance
244.38
⚠️ Risk Line
losing 215.42 would weaken the current structure.
🔺 Technical Setup
Breakout Watch
Downtrend line not broken yet · score 20
Watch Level
230.09
RSI(14)
55.5
🎯 Decision Map
The next meaningful technical decision is likely to occur between support at 215.42 and resistance at 223.94. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
📊 Technical Summary
At a glance
Trend
Constructive
Momentum
Neutral
Range
63% of 52W range
Key Zone
220.42 / 244.38
AbbVie Inc. (ABBV) finished the session at 221.59 (-2.70%). Trend remains constructive above MA50 and MA200. Momentum stays positive (+5.32%); 52W position: 63% of range; and Volatility: ATR14 2.50%. RSI(14) stands around 55.5, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further.
🎯
Key levels: The most important nearby levels are support at 220.42 and resistance at 244.38.
🚀
Trigger: Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup.
💼 Fundamentals Snapshot
Source: sec
💼 Business Lens
QUALITY VIEW
Financial quality snapshot
Financial context is mixed
📈 Growth: Moderate 💰 Profit: Positive 💵 Cash: Pressured 🛡 Balance: Manageable
• Quarterly revenue is still growing, but the pace is cooling from earlier highs.
• Quarterly profitability is positive, though margins are not especially strong.
💵 Revenue
15.00B
📈 Net Income
695.00M
🧮 EPS (Basic)
0.39
🏢 Company
AbbVie Inc.
🏷 Sector
Healthcare
🧩 Industry
Pharma
Compare with related stocks
Same sector and industry ideas for deeper research
Astrazeneca (AZN) technical analysisBristol-Myers Squibb Company (BMY) technical analysisJohnson & Johnson (JNJ) technical analysisELI LILLY & Co (LLY) technical analysisMerck & Co (MRK) technical analysisPfizer (PFE) technical analysisTeva Pharmaceutical Industries (TEVA) technical analysis
WOI OPEN ADVANCED ANALYSIS WORKSPACE
Note: This is an algorithmic technical snapshot (not financial advice).
ABBV Chart